Page last updated: 2024-08-24

gallocatechol and Invasiveness, Neoplasm

gallocatechol has been researched along with Invasiveness, Neoplasm in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baba, K; Hara, Y; Iida, K; Kawaratani, Y; Kushima, Y; Nagaoka, Y; Sakaguchi, M; Shirahama, T; Uesato, S	1
Joo, YE; Jung, YD; Khoi, PN; Lang, SA; Lee, YH; Park, JS; Stoeltzing, O	1

Other Studies

2 other study(ies) available for gallocatechol and Invasiveness, Neoplasm

Article	Year
Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survival; Female; Humans; Neoplasm Invasiveness; Neuregulin-1; Phosphorylation; Protein Multimerization; Receptor, ErbB-2; Receptor, ErbB-3	2009
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells. International journal of oncology, 2013, Volume: 42, Issue:3 Topics: Animals; Catechin; Cell Line, Tumor; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Plant Extracts; Promoter Regions, Genetic; Receptor Protein-Tyrosine Kinases; RNA Interference; RNA, Small Interfering; Stomach Neoplasms; Tea; Tetradecanoylphorbol Acetate; Transcription, Genetic; Xenograft Model Antitumor Assays	2013

Article

Year

Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line.

Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:5

Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survival; Female; Humans; Neoplasm Invasiveness; Neuregulin-1; Phosphorylation; Protein Multimerization; Receptor, ErbB-2; Receptor, ErbB-3

2009

EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.

International journal of oncology, 2013, Volume: 42, Issue:3

Topics: Animals; Catechin; Cell Line, Tumor; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Plant Extracts; Promoter Regions, Genetic; Receptor Protein-Tyrosine Kinases; RNA Interference; RNA, Small Interfering; Stomach Neoplasms; Tea; Tetradecanoylphorbol Acetate; Transcription, Genetic; Xenograft Model Antitumor Assays

2013